Lecardop 25/250 & 25/100 25 mg, 100 mg Tablets.
PDF Leaflet Revision Date: 31 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Parkinsonu2019s disease and syndrome.
Dosage (summary)
Initial: 1 tablet of LECARDOP 25/100 three times daily; titrate as needed.
Onset of Action / Duration
Onset: 1 day, Duration: up to 8 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; excreted in breast milk.
Key Drug Interactions
- Antihypertensives
- Antidepressants
- Iron salts
Contraindications
- Hypersensitivity to components
- Narrow-angle glaucoma
- Severe psychosis
Common side effects
- Dyskinesias
- Nausea
- Confusion
Counselling Points
- Take on an empty stomach
- Monitor for involuntary movements
- Avoid abrupt discontinuation
Serious warnings
- Risk of neuroleptic malignant syndrome
- Impulse control disorders
Important Disclaimer
The Lecardop 25/250 & 25/100 25 mg, 100 mg Tablets. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
